Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Mentor/Fellow Article

Monoclonal Gammopathy of Undetermined Significance—Making it Understandable to Patients

Pamela Rule
Jeannine M. Brant
CJON 2013, 17(6), 614-619 DOI: 10.1188/13.CJON.614-619

Oncology nurses working in ambulatory care often encounter patients with nonmalignant hematologic disorders because the specialties of hematology and oncology are closely entwined. A variety of nonmalignant hematologic disorders can evolve into blood malignancies; therefore, close surveillance of nonmalignant hematologic disorders in an oncology/hematology clinic is important for early detection of malignancy. Monoclonal gammopathy of undetermined significance (MGUS) is one nonmalignant, hematologic disorder that is usually aproblematic; however, it can evolve into a blood malignancy such as multiple myeloma or be associated with other chronic conditions. This article provides an overview of MGUS with a focus on implications for the oncology nurse and patient education.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or